Business ❯ Healthcare

Biopharmaceuticals

Drug Development Oncology Clinical Trials Company Operations Manufacturing Cardiovascular Medicine Immunotherapy Company Profiles Biocon Ltd Market Competition RNA Therapeutics Corporate Partnerships Product Development Biosimilars Research and Development Rare Diseases Gilead Sciences Contract Research Organizations Market Growth FDA Approval Industry Performance Biocon

AstraZeneca Shifts U.S. Listing to NYSE as Nasdaq ADSs End Jan. 30

The move advances a shareholder-approved plan to deliver a single global listing for investors.

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

MPM BioImpact Exits MBX, MoonLake, Crinetics in Q3, SEC Filing Shows

CorMedix Shares Jump After Q3 Beat as Company Lifts 2025 Outlook

Novo Nordisk Licenses Omeros’ MASP-3 Drug in Deal Worth Up to $2.1 Billion

Analyst Warns Eli Lilly’s GLP-1 Lead Is Fading as CFRA Lifts Rating to Buy

Liquidia Reports 900+ Yutrepia Prescriptions in 11 Weeks, Targets Profitability Within 3–4 Quarters